Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.08 | 44.74 |
| PEG Ratio (TTM) | 0.00 | -0.14 |
| P/S Ratio (TTM) | 0.15 | 6.16 |
| P/B Ratio (TTM) | 1.97 | 8.74 |
| P/FCF Ratio (TTM) | -0.18 | 142.90 |
| Price to 5YR AVG Earnings Ratio | N/A | 84.01 |
| Price to 5YR AVG FCF Ratio | N/A | 142.54 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -374.92% | 3.08% |
| ROE (TTM) | -460.17% | 18.80% |
| Net Profit Margin (TTM) | -188.73% | -4.52% |
| ROIC 5YR AVG | N/A | 17.60% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -505.84% | -260.16% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -505.79% | -431.15% | N/A |
| Cash Flow | 7.19% | -686.41% | N/A |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.98 | 1.64 |
| Quick Ratio (TTM) | 5.66 | 1.26 |
| D/E Ratio (TTM) | N/A | 0.71 |
| Interest Coverage (TTM) | N/A | 40.50 |
| Piotroski F-Score | 4 | 5 |
| Altman Z-Score | N/A | 8.59 |
| LTL to 5YR AVG FCF | N/A | -3.77 |
| Shares Outstanding Growth 5YR AVG | N/A | 4.28% |